fashion -WSS

fashion

author：focus 2025-10-02 14:51:34 - browse：53961

Andrew Trister, an oncologist and veteran of big technology companies and research, is Verily's new chief scientific officer.

As Verily aims to get on track, the Alphabet life science company has hired Andrew Trister, an oncologist and veteran of big technology companies and research, as its new chief scientific officer.

Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. He will also consult across Verily’s diverse projects.

Trister’s focus on public health will build on his recent role as a deputy director at the Bill and Melinda Gates Foundation, where he led digital health, including a project to build tech infrastructure to help with malaria testing. Trister also led the foundation’s Covid-19 response. In 2016, he was an early health hire at Apple. There, he worked on programs like a heart health study with Janssen, an app to promote healthy habits with Aetna, and research into digital biomarkers for Alzheimer’s disease with Eli Lilly and Evidation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

focus

WSS

Why we need mandatory labeling of GMO products

Hollywood unions extend contract negotiations for actors

New air purifier tech could be key to improving indoor air quality

How to save PrEP access — and even expand it

The world needs the new pandemic treaty

Novavax promises a turnaround & Lilly roils the obesity market

hotspot

fashion

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Congress: Prevent baby formula shortages by passing a new bill

Tori Bowie and the unacceptable rates of Black maternal death

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Medical records are filled with copy

Continuity nursing helped my family in our darkest PICU moments

United colonoscopy coverage change 'may cost lives,' doctors say

Why some fertility treatments produce more boy babies

Sports medicine is finally prioritizing gender equality

Guardant Health colon cancer test endorsed by FDA advisory panel

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

23andMe had bad news about my health. I wish a person had delivered it

Unmasking the 'centricity' illusion in clinical trials

Medical leaders decry Supreme Court decision on affirmative action

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Bright Health sells Medicare Advantage business to Molina

focus

knowledge

hotspot

explore